Drug Search Results
More Filters [+]

MD-05

Alternative Names: md-05, md05, md 05
Latest Update: 2024-08-22
Latest Update Note: News Article

Product Description

recombinant human GDF-5 coated onto beta-tricalcium phosphate

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Coagulation Factor

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Scil Technology
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MD-05

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Alveolar Bone Loss|Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Scil-MD05-C02

P2

Unknown status

Alveolar Bone Loss

2008-10-01

Scil-MD05-C02

P2

Completed

Unknown

2008-08-26

Sinus Lift Study

P2

Completed

Unknown

2008-03-04

Scil-MD05-C01

P2

Unknown status

Other

2007-12-01

Recent News Events